Further experience with quingestanol acetate as a postcoital oral contraceptive.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003075:Coitus; D003281:Contraceptives, Postcoital / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D009649:Norpregnadienes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D012959:Socioeconomic Factors; D013997:Time Factors
D003281:Contraceptives, Postcoital; D009649:Norpregnadienes